Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Microsoft has hired 24 former DeepMind employees, including Amar Subramanya as its new AI VP, in a major move to strengthen ...

Co-founded by Elon Musk in 2016, Neuralink’s ‘patient one,’ Noland Arbaugh, received the first Brain Chip Implant (BCI) in ...

AI models have just taken a startling step toward autonomy. In a shocking experiment, OpenAI’s o3 model rewrote its own code ...

Jonathan Cohen, who is the director of the Princeton University Neuroscience Institute, and Matthew Botvinick, who is the lead researcher at Google DeepMind, are currently ... legs or changed color ...